Researchers in the United States have conducted a study showing that the Moderna mRNA-1273 vaccine effectively protects against recently emerged variants of severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).<br /><br />The team compared the neutralization activity of blood taken from infected and vaccinated individuals against a panel of SARS-CoV-2 variants, including the B.1.1.7 that emerged in the UK.<br /><br />The team – from Emory University School of Medicine in Atlanta, the University of Texas Medical Branch, and the COVID-19 Neutralization Study Group – found that antibodies generated by both infected and vaccinated individuals effectively neutralized all of the variants.<br /><br />However, as further variants continue to emerge, it will be essential to assess their impact on the potency of neutralizing responses following both infection and vaccination, warns the team.<br /><br />This article was originally written By Sally Robertson for News-Medical.Net on February 8, 2021:<br />http://bit.ly/3cXJvlj<br /><br />FIND the model and photographer created this video on Pexels:<br />https://bit.ly/2MXBylg<br /><br />SUBSCRIBE to our channel:<br />http://bit.ly/3pOwYUZ<br />
